Literature DB >> 23105899

Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.

Kavita K Shalia1, V K Shah, M R Mashru, S L Soneji, J B Vasvani, S Payannavar, A Walvalkar, R Mokal, S S Mithbawkar, M Bootwalla, P Sadvekar, P K Thakur.   

Abstract

Matrix metalloproteinases (MMPs) play important role in the pathogenesis of coronary artery disease (CAD). 5A allele of -1612 5A/6A polymorphism of MMP-3 is associated with two fold higher activity than 6A allele. Present study was designed to analyse the association of this polymorphism with CAD in Indian population. Subjects included in the study were patients with stable angina (n=35), unstable angina (n=53), patients with recent event of myocardial infarction (MI) (MI Group-1, n=56) and patients at presentation of the acute MI (MI Group-2, n=49). Controls were healthy individuals (n=99). Genotyping of MMP-3 5A/6A polymorphism was carried out by PCR-based restriction digestion method. The genotype distribution of patient groups did not deviate from controls. Serum MMP-3 levels were significantly elevated at presentation of the acute MI by 36.8% (P=0.031) as compared to controls and more associated with 6A genotype suggesting discrepancy between in vitro transfection experiment and peripheral MMP-3 levels.

Entities:  

Keywords:  Coronary artery disease; Matrix metalloproteinase-3; Myocardial infarction; Single nucleotide polymorphism; Stable angina; Unstable angina

Year:  2010        PMID: 23105899      PMCID: PMC3453096          DOI: 10.1007/s12291-010-0025-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  26 in total

Review 1.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

2.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

Authors:  A M Henney; P R Wakeley; M J Davies; K Foster; R Hembry; G Murphy; S Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

4.  Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.

Authors:  M Terashima; H Akita; K Kanazawa; N Inoue; S Yamada; K Ito; Y Matsuda; E Takai; C Iwai; H Kurogane; Y Yoshida; M Yokoyama
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

5.  Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.

Authors:  S Ye; P Eriksson; A Hamsten; M Kurkinen; S E Humphries; A M Henney
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

6.  Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis.

Authors:  S Ye; G F Watts; S Mandalia; S E Humphries; A M Henney
Journal:  Br Heart J       Date:  1995-03

7.  Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.

Authors:  Giorgio Ghilardi; Maria Luisa Biondi; Marco DeMonti; Olivia Turri; Emma Guagnellini; Roberto Scorza
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

8.  Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.

Authors:  P K Shah; E Falk; J J Badimon; A Fernandez-Ortiz; A Mailhac; G Villareal-Levy; J T Fallon; J Regnstrom; V Fuster
Journal:  Circulation       Date:  1995-09-15       Impact factor: 29.690

9.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

10.  Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease.

Authors:  Anthony J White; Stephen J Duffy; Anthony S Walton; Jer Fuu Ng; Gregory E Rice; Swati Mukherjee; James A Shaw; Garry L Jennings; Anthony M Dart; Bronwyn A Kingwell
Journal:  Cardiovasc Res       Date:  2007-05-10       Impact factor: 10.787

View more
  3 in total

1.  Role of matrix metalloproteinase 3 gene promoter polymorphism in chronic pancreatitis.

Authors:  K Sri Manjari; D Krishnaveni; A Vidyasagar; B Prabhakar; A Jyothy; Pratibha Nallari; A Venkateshwari
Journal:  Indian J Gastroenterol       Date:  2011-09-24

2.  Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.

Authors:  Hari Om Singh; Shruti D Marathe; Sumitra Nain; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

3.  The effect of gender and genetic polymorphisms on matrix metalloprotease (MMP) and tissue inhibitor (TIMP) plasma levels in different infectious and non-infectious conditions.

Authors:  J Collazos; V Asensi; G Martin; A H Montes; T Suárez-Zarracina; E Valle-Garay
Journal:  Clin Exp Immunol       Date:  2015-09-11       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.